Skip to main content
Clinical Trials/JPRN-UMIN000016612
JPRN-UMIN000016612
Completed
未知

AFIRE Study: Atrial Fibrillation and Ischemic events with Rivaroxaban in patiEnts with stable coronary artery disease Study - AFIRE Study

Japan Cardiovascular Research Foundation0 sites2,200 target enrollmentFebruary 23, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
on-valvular atrial fibrillation
Sponsor
Japan Cardiovascular Research Foundation
Enrollment
2200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 23, 2015
End Date
September 30, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Patients who are contraindicated for rivaroxaban 2\)Patients who are contraindicated for aspirin, thienopyridine derivatives (clopidogrel or prasugrel) 3\)Patients who underwent PCI, including POBA, in the past one year 4\)Patients who are going to undergo revascularization 5\)Patients who have a past history of stent thrombosis 6\)Those who are going to undergo invasive surgery (excluding digestive endoscopy and biopsy) 7\)Patients who have active tumors 8\)Patients who have poorly\-controlled hypertension (systolic blood pressure at hospital admission based on two or more measurements: 160 mmHg or more) 9\)Patients who cannot discontinue treatment with antiplatelet drugs (the physician in charge will make a decision on the basis of the lesion shape, lesion site and type of stents.) (10\)Patients judged as inappropriate for this study by investigators Contraindicated for rivaroxaban (1\)Unstable CAD (2\)Patients with a past history of stent thrombosis (3\)Patients judged as inappropriate for this study by investigators

Outcomes

Primary Outcomes

Not specified

Similar Trials